Second, due to the lack of detailed information on the patients, this study did not analyze the associations between BAX, BCL2 and c-MYC polymorphisms and gene expression and clinical features, such as tumor size and sensitivity to treatment. The gene discussed is BCL2; the disease is neoplasm.